Arena Pharmaceuticals, Inc. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6a56a21c-c17a-474b-9714-b2b584984e70/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-624.3M | 2021-01-01 – 2021-12-31 | evidence 0001080709-22-000006 |
| FY 2020 | $-426.6M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-007609 |
| FY 2019 | $482.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-007399 |
| FY 2018 | $-144.8M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005441 |
| FY 2017 | $-92.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005660 |
| FY 2016 | $-5.3M | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-005660 |
| FY 2015 | $-103.5M | 2015-01-01 – 2015-12-31 | evidence 0001564590-18-005660 |
| FY 2014 | $-105.3M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-073420 |
| FY 2013 | $-22.9M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-080400 |
| FY 2012 | $-57.1M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-087866 |
| FY 2011 | $-82.8M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-117359 |
| FY 2010 | $-96.4M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-117359 |
| FY 2009 | $-138.4M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-117359 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Arena Pharmaceuticals, Inc. — all facts · Revenue · Net Income